Intrasense Past Earnings Performance

Past criteria checks 0/6

Intrasense's earnings have been declining at an average annual rate of -36.7%, while the Healthcare Services industry saw earnings growing at 6.8% annually. Revenues have been declining at an average rate of 1.2% per year.

Key information

-36.7%

Earnings growth rate

-18.9%

EPS growth rate

Healthcare Services Industry Growth7.9%
Revenue growth rate-1.2%
Return on equity-73.6%
Net Margin-166.9%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Intrasense makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:I8S Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 242-410
31 Mar 243-420
31 Dec 233-420
30 Sep 234-320
30 Jun 234-320
31 Mar 234-320
31 Dec 224-320
30 Sep 224-310
30 Jun 224-200
31 Mar 224-210
31 Dec 214-110
30 Sep 214-120
30 Jun 214-130
31 Mar 214-130
31 Dec 203-130
30 Sep 203-130
30 Jun 203-120
31 Mar 203-120
31 Dec 193-110
30 Sep 194-110
30 Jun 194-100
31 Mar 194-100
31 Dec 184-200
30 Sep 183-200
30 Jun 183-210
31 Mar 183-210
31 Dec 173-200
30 Sep 173-200
30 Jun 173-200
31 Mar 174-200
31 Dec 164-200
30 Sep 164-200
30 Jun 164-200
31 Mar 164-200
31 Dec 154-300
30 Sep 154-400
30 Jun 153-500
31 Mar 153-500
31 Dec 143-500
30 Sep 144-400
30 Jun 145-310
31 Mar 145-210
31 Dec 135-210

Quality Earnings: I8S is currently unprofitable.

Growing Profit Margin: I8S is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: I8S is unprofitable, and losses have increased over the past 5 years at a rate of 36.7% per year.

Accelerating Growth: Unable to compare I8S's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: I8S is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (3.6%).


Return on Equity

High ROE: I8S has a negative Return on Equity (-73.59%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 16:20
End of Day Share Price 2024/12/23 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Intrasense S.A. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mickael DubourdAurgalys SAS
Mickael Chane-DuGilbert Dupont
Jean-Pierre LozaIn Extenso Financement & Marché